Vitiligo — Treatment Options Study tool · source: Oct 2026 review · works offline ◐ T Click the tool once to enable keys: R L C Q D S F switch mode · T theme · 1–4 choose · Enter check/next · Space flip · ← not yet · → got it Sources (compiled Oct 2026): International Vitiligo Task Force incl. 2026 Consensus on Severity and Relapse; Canadian Consensus Guidelines 2025; Japanese Vitiligo Guideline 2026; FDA and EMA ruxolitinib cream product information; NEJM TRuE-V1/TRuE-V2; JEADV 2026 long-term data; IADVL surgical consensus 2024–2025. The supplied source text ends mid-way through depigmentation therapy (monobenzone), so that section is incomplete. Educational use only — not clinical advice. Arabic notes are study aids, not part of the source.
DrugPamphlet is your comprehensive online guide to medications available in Egypt. We provide detailed commentaries on Egyptian drug brands, covering their indications, dosage, characteristics, side effects, and interactions. Our mission is to enrich the field of pharmaceutical information by adding useful knowledge, resources, and perspectives on medicines and pharmaceutical products.